This topic contains a solution. Click here to go to the answer

Author Question: James Pennebaker has demonstrated that A) writing or talking about traumatic events can produce ... (Read 125 times)

Ebrown

  • Hero Member
  • *****
  • Posts: 567
James Pennebaker has demonstrated that
 
  A) writing or talking about traumatic events can produce positive results.
  B) relaxation training is more effective than biofeedback to address pain.
  C) social support is critical in helping patients to cope with chronic pain.
  D) social support is not critical in helping patients cope with chronic pain.

Question 2

Cognitive behavioral therapy
 
  A) concentrates on developing attitudes that change behaviors.
  B) emphasizes attitudes while minimizing the role of behavior.
  C) focuses on analyzing irrational beliefs rather than behavior.
  D) is characterized by both (b) and (c) more strongly than (a).



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jackie

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

A

Answer to Question 2

A




Ebrown

  • Member
  • Posts: 567
Reply 2 on: Jun 21, 2018
Excellent


Animal_Goddess

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library